Millennium Management »

Atara Biotherapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Atara Biotherapeutics shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $992k 117k 8.50

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding Atara Biotherapeutics

Redmile Group
EcoR1 Capital
Citadel Advisors
Bank of America Corporation
Vanguard Group
Centiva Capital
Acadian Asset Management
Millennium Management
Vestal Point Capital
Qube Research & Technologies
Tang Capital Management
Woodline Partners
BlackRock
Renaissance Technologies
Geode Capital Management

View all funds holding Atara Biotherapeutics